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ABSTRACT  
All equipment’s used in the production of products shall be properly Validated, Qualified and Calibrated to demonstrate that it is suitable for its 
intended purpose. Qualification is an important aspect of the pharmaceutical quality system. When the equipment is properly qualified, verified 
and maintained, there is the possibility of Consistent performance of the equipment. A well designed qualification program saves valuable time 
and cost. Qualification is called a cyclic process because it is a never ending process. Appropriate documentation of the qualification program is 
very important as lack of the documented evidence does not give any meaning to qualification (Not documented it means not done).  The 
current programs and procedures of equipment qualification used within any pharmaceutical and bioscience industry are based on ‘regulatory 
requirements’, ‘voluntary standards’, ‘vendor practices’, and ‘industry practices’. The output is considerable variation in t he way any 
pharmaceutical and biotechnological companies approach for the laboratory equipment. The lifecycle management approach of equipment 
qualification covers entire life cycle for the specification, design, manufacturing, installation, commissioning, qualification (4Qs Model DQ, IQ, 
OQ, PQ), operation & maintenance of equipment in a risk based life cycle management approach. The goal of any regulated pharmaceutical and 
bioscience company is to provide reliable and valid data suitable for its intended purpose. Main goal of equipment qualification is to form the 
basis for written procedures for production and process control which are designed to assure that the drug products have the SISPQ (Safety, 
Identity, Strength, Purity and Quality) 
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Introduction: 
Equipment Qualification: It is the action of proving 
documented evidence demonstrating that equipment is 
designed/selected adequately, installed and 
operates/performs properly for its intended purpose. These 
activities have been divided into main four phases of 
qualification.1 These are listed as: Design, Installation, 
Operational and Performance qualifications.  
Objectives of Equipment Qualification: 
1) To review the requirements of equipment 
 Selection 
 Design 
 Use 
 Maintenance 
2) To discuss the equipment qualification principles, 
specifically focusing on: 
 The different stages of qualification 
 Requalification  
 Qualification of “in use equipment” 
3) To form the basis for written procedures  for 
production and process control which are designed to 
assure that the drug products have the SISPQ(Safety, 
Identity, Strength, Purity and Quality) 
4) To improve and control overall production reliability 
and availability 
5) To ensure safety of products 
Schedule M states proper concepts about the qualification of 
the equipment.2 Qualification requirements of established 
equipment are decided on the basis of available historical 
data of that equipment. 3. As per good laboratory practice 
rules and regulations impose similar requirements, asset 
used for the generation, measurement, or assessment of data 
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shall be adequately tested, calibrated and/or standardized. 4-
5 
 Documentation: 
This section provides guidelines on those requirements 
relating to documentation covering the EQ process. 
Appropriate documentation of the qualification program is 
very important as lack of the documented evidence does not 
give any meaning to qualification (Not documented it means 
not done). It should not be intended to cover other 
documentation reports relating to operation or servicing 
(e.g. manuals) of the instrument. 6 
 
 
 Stages of Equipment Qualification:7 
 
Fig 1: Stages of Equipment Qualification 
 Responsibilities:8 
1) URS:  
 User department- to prepare URS 
 Engineering department/ Vendor – to verify  
2) DQ : 
 Engineering department/ Vendor: DQ Protocol 
  User department: to verify 
3)  IQ: 
 Engineering department/ Vendor: IQ Protocol 
 User department: to review 
 QA department: to approve 
4) OQ: 
 Engineering department/ Vendor: IQ Protocol 
  User department: to review 
 QA department: to approve 
5) PQ: 
 Engineering department/ Vendor: IQ Protocol 
 User department: to review 
 QA department: to approve 
 Gap analysis:  
The gap analysis contains a short, observes GLP lineament, 
regulatory requirements, and is convenient for the process 
and validation strategy. It has the management of 
qualification execution plan, and makes a lot of facility 
maintenance validity.9 Gap analysis includes the 
responsibility of applicable personnel, characteristics of 
equipment to be evaluated, the model number, serial 
manufacture number, serial asset number, using purpose, 
location, document or SOP, number, equipment logs, date of 
last calibration, personnel training records, a validation 
certificate, system controls, data storage methods, risk type, 
the level of the responsible person, and validation specialist 
Qualification study director). Gap analysis offers the easy 
and convenient information for the validation process. The 
qualification study director wants to cooperate with the 
manufacture or vendor, and to notify any abnormality of the 
facility to them. The document for gap analysis is similar to 
those shown in Table 1. 
Table 1: Gap Analysis Record 10 
Sr.no 1 2 3 4 
Equipment-Asset     
Make     
Model No.     
Serial No     
Inst.ID.     
Software     
21 CFR compliant status     
Critical/Non Critical Calibration     
IQ/OQ/PQ     
SOP No     
Document Archival     
Location     
Remark     
 
URS  
(USER 
REQUIREMENT 
SPECIFICATION 
DQ (DESIGN 
QUALIFICATION)  
FAT 
(FACTORY 
ACCEPTANCE TEST 
) 
SAT  
(SITE ACCEPTANCE 
TEST) 
IQ 
(INSTALLATION 
QUALIFICATION) 
OQ 
(OPERATIONAL 
QUALIFICATION) 
PQ (PERFORMANCE 
QUALIFICATION) 
RQ 
(RE-QUALIFICATION) 
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I.  User Requirement Specification 
The specification for equipment shall be defined in a URS. 
The set of owner, user and engineering requirements 
necessary and sufficient to create a feasible design meeting 
the intended purpose of the system and any GMP risks 
mitigated to an accepted level. The URS shall be a point of 
reference throughout the validation life cycle. URS may be 
considered as the first initial and important step in the 
qualification “flowchart”, which can be shown in the figure 
above (Fig. 1):  
The URS shall cover the specific requirements of the 
equipment to be procured. 
The user department shall prepare the URS for the new 
equipment, utility and system considering the principles, 
requirements and precautions that should be followed to 
safeguard product quality, EHS objectives, GMP and GEP on 
site. 
The contents of URS shall include the following but not 
limited to; 
 Name o Machine 
 Purpose of machine 
 Size/capacity 
 MOC 
 Change parts 
 Working condition requirements 
 Electrical requirements 
 Utility requirements 
 Control panel 
 Display requirements 
 Software requirements 
 cGMP requirements 
 Safety requirements 
 Document requirements 
II. Design Qualification 
The DQ confirms that the design of the equipment is 
appropriate and meets with the URS. DQ shall be done based 
on the product/process requirements. The compliance of the 
design with cGMP shall be demonstrated and documented 
during design review.11  
Design qualification is combination of user requirement 
specification, design specification, and functional 
requirement specification  
Design Qualification is used when a design that has been 
developed from the URS is reviewed and commented on by 
competent persons to ensure that the designed equipment, 
while built properly, it will satisfy all the detailed specified 
requirements.  It can also be used to review of the shelf item 
to ensure it will satisfy the URS. 
User Requirement Specifications consisting of design and 
functional specifications for the equipment shall be verified 
with the actual equipment details (design and functional) 
offered by the Supplier. This is called Design Qualification 
and this is a documentation activity and recommended to be 
completed before the PO is placed (if applicable). 
The design qualification protocol shall be given by vendor 
and in case vendor does not provide the DQ document; 
engineering department shall prepare the DQ in 
coordination with user department and manufacturer / 
supplier in reference with URS. The DQ protocol shall be 
prepared for each equipment based on the quotation / 
proposal and technical discussions between supplier and 
user department.7 The DQ protocol must cover all the 
necessary diagrams, layouts, location suitability and desired 
special feature of components, equipment components and 
their specification, desired material of construction (MOC), 
location of control panel, electrical requirement and utility 
requirement. The compliance of the design with cGMP and 
also with the specification must be introduced and 
documented as per general guidance mentioned in given 
Qualification protocol. 12 
III. Factory Acceptance Test (FAT) 
Equipment, especially if incorporating novel or complex 
technology, it shall be evaluated at the vendor site prior to 
delivery. Team from user engineering and QA shall perform 
the Factory Acceptance Test (FAT) at Vendor’s site after 
fabrication of equipment and before dispatch to company 
site, to ensure that the equipment is build/fabricated with 
the required functionality as specified in URS/DQ. The FAT 
shall be documented in supplier’s document and the 
contents of FAT documents shall include at least the 
following but limited to; 
1) Visual inspection of components: This includes the 
verification of Dimensions, Motor, Blower specification, 
MOC, Valves (Size/No) and safety requirements 
(Alarm/Interlocks). 
2) Critical operational requirements: This includes the 
verification of critical operations based on URS. 
3) Operational test (If applicable): The critical 
operations shall be performed under FAT. 
If equipment is identified as critical/sophisticated, FAT 
shall be performed depending upon the complexity of 
equipment. 
IV. Site Acceptance Test (SAT) 
SAT shall be applicable for the major customized machines. 
Vendor shall provide the SAT documents and if vendor does 
not provide the SAT protocol, In-House protocol shall be 
prepared by engineering department in coordination with 
user. SAT shall be performed by relevant subject matter 
experts of different functional areas like Engineering, 
Production, QA  & QC at company site, after the receipt of 
equipment with the following objectives; 
1) To inspect and ensure that the equipment received at 
company site is in good state and no components are 
damaged during transportation. 
2) To provide documented evidence that the equipment 
received at company site is in good state and meeting 
as designed. 
 The main contents of SAT shall include, but is not 
limited to, the following; 
1)  Equipment details 
2) Receipt of consignment 
3) Inspection of equipment consignment 
4) Inspection of equipment 
5) Inspection of major components 
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6) Accessories/Spare parts 
7) Master documents- Maintenance/User’s 
manual/Calibration certificate. 
V. Installation Qualification 
Documented verification that all aspects of a system, facility, 
utility or equipment that can affect product quality are 
installed or modified, comply with the approved design and 
the manufacturer’s recommendations.13 IQ applies to a new, 
pre-owned or an existing onsite but not to already existing 
qualified instrument.14 The activities and documentation 
associated to IQ are as follows:  
IQ shall be performed on new or modified equipment, for 
establishing the evidence that all key aspects of the process 
equipment and ancillary system installation as per the 
requirements of Company’s approved specification and 
recommendations. 
The main contents of IQ include but are not limited to, the 
following: 
 Physical verification of equipment 
 Manufacturer specification verification 
 Purchase order specifications 
 Piping and installation drawing (P&ID) 
 Construction and installation 
 Component verification 
 Test equipment’s instrument calibration 
 Critical component calibration requirements 
 Required spare parts 
 Cleaning/Passivation 
 Weld inspection 
 System installation compliance to cGMP 
 Change/Replacement spare parts 
 Physical verification of area 
 Verification of Material of construction 
 Identification of instrument to be calibrated 
 Verification of utilities 
 Verification of safety features 
 Identification/preparation of SOPs for operation, 
cleaning, calibration and Preventive maintenance. 
IQ protocol shall be provided by vendor and shall be 
reviewed and approved from user and engineering 
department. After approval, QA department shall authorize 
the protocol for further execution. 
After completion of an execution by vendor, provided 
documents review of executed protocol, raw data shall be 
done by user, engineering and QA. After successful 
completion of the protocol activity, initiate the post approval 
to close the document. 
In case vendor is not providing the installation qualification 
document, user department shall prepare the in house 
protocol in coordination with engineering and QA. After 
successful completion of the protocol activity, all instrument 
associated with the equipment shall be identified and shall 
add in the master list of instrument as applicable. 
 Installation Qualification to be re-qualified in case 
of: 
 Transferring of the equipment from one location to 
another (excluding portable type). 
 In case of major changes or to address the qualification 
of newly added component 
VI. Operational Qualification 
After successful completion of the IQ protocol activity, 
operational qualification shall be performed to verify that 
the equipment operates in accordance with design 
specifications, manufacturer recommendations and meeting 
the operational cGMP requirements. 
Documented verification that all angless and functions of a 
system, facility, utility or equipment that can affect quality of 
product, operate properly within all anticipated operating 
ranges as required by the process, capability, procedures 
and design specification.  
The OQ phase focused on following parameters:  
All testing equipment shall be identified and calibrated 
before use. Test methods shall be authorized; implemented 
and resulting data shall be collected and evaluated. It is 
important at this stage to assure all operational test data 
conforms to predetermined acceptance criteria for the 
studies undertaken. 
OQ protocol shall be provided by the vendor and shall be 
reviewed and approved from the user and engineering 
department. After approval QA department shall authorize 
the protocol for further execution.  
After completion of an execution by vendor, provided 
documents review of executed protocol, raw data shall be 
done by user, engineering and QA. After successful 
completion of the protocol activity, initiate the post approval 
to close the document. 
The OQ shall be performed in accordance with the pre-
approved written protocol. 
 The contents of OQ shall include at least the following 
but not limited to; 
 Calibration review of critical instruments/components. 
 Calibration review of reference test 
equipment/instrument. 
 Methodology for operational procedure to includes the 
tests that have been developed from knowledge of 
processes, systems and equipment to ensure the 
system is operating as designed. 
 Test including the conditions encompassing upper and 
lower operating limits, and/or “worst condition”. 
 Testing of safety features and alarm testing 
 Power failure verification 
 Computer system validation 
 Verification of SOP 
 Verification of PM 
 Testing to concerned persons 
OQ shall be performed as a combined Installation/ 
operational qualification i.e. IOQ and IOPQ. If IOPQ needs to 
be performed same format shall be used for protocol 
preparation and PQ test shall be incorporated as required. 
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The completion of a successful OQ shall allow the finalization 
of SOP & cleaning procedures, operator training and PM 
requirement. 
 Operational Qualification to be re-qualified in case 
of: 
 Transfer of the equipment from one location to 
another (excluding portable type). 
 In case of major changes or to address the qualification 
of newly added component, RQ shall be requied. 
VII. Performance Qualification 
After successful completion of the IQ protocol activity, 
operational qualification shall be performed to verify that 
the equipment or equipment under anticipated conditions, 
providing the consistent performance to produces a product, 
which meets all predetermined requirements. 
Documented verification that all aspects of a system, facility, 
utility or equipment that can affect product quality produce 
the required output over an extended period under typical 
operating conditions and interferences.  
PQ shall be carried out in accordance with a preapproved 
written protocol. The specific PQ attributes developed from 
the finished product specifications, R&D data, cGMP 
requirements and other specific documentation shall be 
verified along with the acceptance criteria. 
SOP of “operation and cleaning of equipment” and “PM 
procedure” must be approved prior to start the PQ. 
The data generated under PQ shall not be considered for 
routine production and for human use. It shall be restricted 
to the qualification purpose only. 
The PQ test shall be considered successful if all the test 
results are meeting the acceptance criteria. 
If vendor provided PQ protocol is available then it shall be 
reviewed and approved from user and engineering 
department. After approval QA department shall authorized 
the protocol for further execution. 
After completion of the execution of vendor provided 
documents review of executed protocol, raw data shall be 
done by user, engineering and QA. After successful 
completion of the protocol activity, initiate the post approval 
to close the document. 
In case if vendor is not providing the PQ document, user 
department shall prepare the in  house protocol in 
coordination with engineering department and QA. 
PQ must include the following but not limited to; 
 Prerequisite for PQ 
 Tests, with production materials, qualified substitutes 
or simulated products that have been developed from 
knowledge of the process and the equipment. 
 Tests including the condition or set of conditions 
encompassing upper and lower operating limits (worst 
case). 
 Qualification done or documented by the equipment 
supplier shall be also accepted after reviewing it for 
adequacy and approving by the responsible personnel 
from company. 
 After successful completion of PQ, QA shall release the 
equipment for routine operation.  
During PQ, equipment shall be qualified for the entire 
operating range as per DQ. However, PQ can also be 
performed simultaneously with process validation of 
product to cover the complete range of product 
manufactured. For such qualification, summary report of 
validation activity shall be prepared and it report shall 
attached with qualification documents.15 
 Performance Qualification to be re-qualified in 
case of: 
 Replacement/ modifications of existing equipment/ 
component in the equipment with a new one, which 
can have a direct impact on the performance of the 
equipment. 
 Any major changes to the existing Equipment/System, 
which can affect the overall performance of the 
equipment. 
 If system founds malfunctioning during performance 
qualification. 
VIII. Re-Qualification 
 Re-Qualification is an activity involving complete or 
portions of ‘elements’ of qualification activities, like IQ, 
OQ and PQ. 16 
 Re-Qualification carried out for following reasons: 
 To overcome deficiencies observed in an  qualification 
 Need for any new additions in qualification tests 
 To qualify modifications done in the equipment or a 
process involving an equipment 
Failure 
 Findings/Recommendations from Inspections/Audits/ 
PQR, etc. 
 Inputs from Preventive Maintenance/Calibration 
Program 
 Equipment Up-gradation 
 To testing of the elements impacted by the changes or 
qualification parameters found to be deficient, all 
critical components of the equipment verified for 
functionality during Re-Qualification. 
 Risk Assessment/ Risk Management: 
Qualification is to accomplish written evidence that 
processes and equipment work within their specifications to 
get quality products. Working with processes and 
equipment, there are always risks that may or may not be 
acceptable.17 To ensure about the product quality, a crisis 
evaluation or quality risk management shall be performed. 
 To assess the potential critical and non-critical points 
of the process or equipment. 
 Critical Equipments: These are the equipments that 
comes into direct contact with product which may 
affect on the SISPQ (Safety, Identity, Strength, Purity & 
Quality) of products. Critical equipment often impacts 
safety, regulatory confirmity, cost, or operational 
procedures output.18 
E.g.; Laminar air flow, PH meter, HPLC, PCR, Homogeniser, 
Fermenter, Downstream chromatographic system (AKTA) 
etc. 
 Non-critical Equipments: These are the equipments 
that do not comes into direct contact with product and 
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not affecting SISPQ (Safety, Identity, Strength, Purity & 
Quality)  of products. 
E.g.; Refrigerator, Centrifuge, Weighing balance, CO2 
incubator, etc. 
 Using three dimensional risk factors like severity, 
probability and detectability, risk shall be quantified. A 
risk probability number (RPN), is calculated based on 
these three factors.  
 Risk priority number (RPN) assessment is a function, 
the severity of the effect of failure, the probability of 
occurrence, and the ease of detection for each failure 
mode. RPN is calculated as per the formula below, 
 
RPN=S×O×D 
Where,  
S - the severity of the effect of failure,  
O - the probability of occurrence, and  
D - the ease of detection. 
In the choice of an action against failure modes RPN may not 
have any role, but it will help in indicating the threshold 
values for determining the areas of greatest concentration. 
In other words, a failure mode with a high RPN number 
should have the highest priority in the analysis and 
corrective action. 
 Risk Based approach Impact Assessment should be 
focusing on product impact. Every Equipment need to 
be classified between Direct impact, Indirect Impact, or 
No Impact to the product. 
 Purpose of the equipment impact Risk Assessment  
 Determine Equipment criticality based on impact to 
Product safety.  
 Determine level of qualification required for new 
Direct Impact Equipment. 
 Determine level of qualification required when 
changes are made in qualified Equipment. 
 Form FDA 483 issuance related to Equipment 
Qualification:. 
A Form 483, also called "Inspectional Observations," is a list 
of conditions or practices that indicate a potential violation 
of the FDA's requirements.19 The FDA has authority to 
inspect factories that manufacture products regulated by the 
FDA.20 FDA inspectors can come in to firm and can  
inspect any given facility at any time, and they essentially 
write down their observations on a form called Form FDA 
483s. The observations are listed in descending order of 
importance for the corrections. This is not an all-inclusive 
list, but more of a snapshot of possible issues noted at the 
site.21-22 There are multiple examples of issuance of form 
483 related to qualification of equipments. Hence there is a 
need of robustness and raggedness in analytical procedure 
while performing the process of equipment qualification. 
There are few examples of observations in form 483 related 
to equipment qualification: 
E.g.; Observation: Form 483 is issued by Cipla Ltd., 
Salcette Goa, India on the date of 25/01/2018 
As per FDA, Assets used in the process of manufacture, 
processing, packing or holding of drug products is not of 
appropriate design to facilitate operating procedure for its 
intended use. 
Specifically, you do not always adequately qualify/requalify 
equipment used for the manufacturing of drug products such 
as Capsules in that: 
a) Company not have an approved protocol for 
equipment requalification of their Encapsulation 
machine moved from Unit to Unit with acceptance 
criteria for each critical variable prior to initiation of 
performance requalification operations. 
b) Company not have data showing their Encapsulation 
machine which is capable for successful operating 
procedure over the full range of their acceptance 
criteria for critical variables.23 
Conclusion: 
This article presents an approach to life cycle management 
of equipment & it's qualification. In a risk based life cycle 
management approach, it covers the entire life cycle for the 
various stages of specification, design, manufacture 
installation, commissioning, qualification, operation and 
maintenance of the equipment. The success of equipment 
qualification is mainly depends on the good engineering 
practices followed in the organization. Appropriate 
documentation of the qualification program is very 
important as lack of documented evidence does not give any 
meaning of qualification. A relationship between user & 
supplier by  building program, the redundancies can be 
reduced and provide significant advantage for both parties. 
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 Abbreviations:  
 E.g. – Example 
 SOP – Standard Operating Procedure 
 SYS- System  
 URS – User Requirement Specification 
 DQ – Design Qualification 
 FAT – Factory Acceptance Test 
 SAT – Site Acceptance Test 
 IQ – Installation Qualification 
 OQ – Operational Qualification 
 PQ – Performance Qualification 
 RQ – Requalification 
 SISPQ – Safety, Identity, Strength, purity and Quality 
 RPN – Risk Priority Number 
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